US 7935351
Use of CPG oligodeoxynucleotides to induce angiogenesis
granted A61KA61K31/711A61P
Quick answer
US patent 7935351 (Use of CPG oligodeoxynucleotides to induce angiogenesis) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Apr 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue May 03 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K31/711, A61P, A61P9/00